Pharmacy Focus: Psychedelic Pharmacy - Investigating Ketamine for Chronic Pain Management, Addiction Treatment

This month, we spoke with Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, about ketamine and the future of the opioid epidemic.

This month, we spoke with Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, about how investigative psychedelic treatments could help treat both chronic pain as well as addiction, and what this could mean for the future of the opioid epidemic.

Related Videos
Related Content

Research Finds Impact of Chronic Pain on Daily Life is Biggest Threat to Mental Health

March 10th 2023

Independent Rx Forum - Five Trends in Community Pharmacy

March 22nd 2023

There Remain Startling Health Inequities in the Treatment of Substance Use Disorder

February 22nd 2023

Pharmacy Focus: Oncology Edition - Breast Cancer Treatments Are Rapidly Expanding

March 20th 2023

FDA Advisory Committees Recommend Naloxone Be Available OTC

February 16th 2023

Prioritizing Patient Pain Before Surgery Can Help Change the Trajectory of the Opioid Epidemic

February 9th 2023

Research Finds Impact of Chronic Pain on Daily Life is Biggest Threat to Mental Health

March 10th 2023

Independent Rx Forum - Five Trends in Community Pharmacy

March 22nd 2023

There Remain Startling Health Inequities in the Treatment of Substance Use Disorder

February 22nd 2023

Pharmacy Focus: Oncology Edition - Breast Cancer Treatments Are Rapidly Expanding

March 20th 2023

FDA Advisory Committees Recommend Naloxone Be Available OTC

February 16th 2023

Prioritizing Patient Pain Before Surgery Can Help Change the Trajectory of the Opioid Epidemic

February 9th 2023

Research Finds Impact of Chronic Pain on Daily Life is Biggest Threat to Mental Health

March 10th 2023

Independent Rx Forum - Five Trends in Community Pharmacy

March 22nd 2023

There Remain Startling Health Inequities in the Treatment of Substance Use Disorder

February 22nd 2023

Pharmacy Focus: Oncology Edition - Breast Cancer Treatments Are Rapidly Expanding

March 20th 2023

FDA Advisory Committees Recommend Naloxone Be Available OTC

February 16th 2023

Prioritizing Patient Pain Before Surgery Can Help Change the Trajectory of the Opioid Epidemic

February 9th 2023
© 2023 MJH Life Sciences

All rights reserved.